"Why AlphaNorth Asset Mgmt holds 13% of AGN's shares" "Why One Fund Owns 13% of This Small-Cap Pharma"
https://www.streetwisereports.com/article/2022/12/12/why-one-fund-owns-13-of-this-small-cap-pharma.html
Insightful article on AGN's multiple pipelines and why AlphaNorth Asset Management holds ~13% of the firm’s shares!
“We like it primarily because of the valuation. It’s quite cheap. Currently, the value of the whole company is CA$6–7 million. We also like it because they have multiple programs; I like companies like have multiple shots on goal, so to speak. And the trials that they are conducting are also lower risk than the typical biotech because they are using drugs that are already known to be safe.”